NCT06873659View on ClinicalTrials.gov

SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

February 26, 2025

Primary Completion Date

April 30, 2027

Study Completion Date

November 30, 2027

Conditions
Solid TumorGastric CancerLiver Cancer
Interventions
DRUG

SON-DP

Solution for IV administration

Trial Locations (11)

100021

NOT_YET_RECRUITING

Cancer Hospital Chinese Academy of Medical Sciences, Beijing

100142

RECRUITING

Beijing Cancer Hospital, Beijing

102200

RECRUITING

Beijing GoBroad Hospital, Beijing

200032

RECRUITING

ZhongShan Hospital Fudan University, Shanghai

210029

RECRUITING

Jiangsu Province Hospital, Nanjing

250117

RECRUITING

Introduction to Cancer Hospital of Shandong First Medical University (Shandong Cancer Institute,Shandong Cancer Hospital), Jinan

310022

RECRUITING

Zhejiang Cancer Hospital, Hangzhou

510060

RECRUITING

Sun Yat-sen University Cancer Center, Guangzhou

RECRUITING

Sun Yat-sen University Cancer Center, Guangzhou

710061

RECRUITING

The First Affiliated Hospital of Xi 'an Jiaotong University, Xi'an

730000

RECRUITING

The First Hospital of Lanzhou University, Lanzhou

All Listed Sponsors
lead

Qurgen Inc.

INDUSTRY